Background: Cardiac arrhythmias in critically ill patients often cause severe hemodynamic impairment or medical complications, precipitating rapid deterioration of patients' conditions. This manuscript describes common or fatal cardiac arrhythmias occurring in patients hospitalized at intensive care units. Results: Differential diagnosis of wide QRS tachycardias includes ventricular tachycardias (VTs), supraventricular tachycardias with aberrant conduction and noise artifacts. Idiopathic VTs in patients with structurally normal hearts are responsive to antiarrhythmic agents and are cured by catheter ablation. Ventricular tachycardias in structural heart diseases require amiodarone for acute suppression and implantable defibrillator for longterm management. Polymorphic VTs or Torsades de Pointes are effectively suppressed by intravenous infusion of magnesium. Discontinuation of offending agents and, in some refractory cases, installation of temporary pacing is necessary. Atrial fibrillation (AF) is the most commonly observed tachyarrhythmias in intensive care settings. When combined with sepsis or congestive heart failure, AF with rapid ventricular response induces hypotension and sympathetic stimulation, which again aggravates rapid ventricular responses. This viscious cycle continues until adequate rate control measures are initiated. Intravenous amiodarone and anticoagulation are important initial management. In rare cases, electrical noises mimic ventricular tachycardias. Noises are distinguished from true VTs by identification of sharp QRS notches and stable hemodynamics during the events. Conclusion: Proper interpretation of monitoring or standard ECG is crucial for differential diagnosis of cardiac arrhythmias occurring in intensive care units. Management should be tailored based upon arrhythmia characteristics and individual medical conditions.
Lidocaine is effective for the control of ventricular tachyarrhythmias in patients with ischemic heart diseases. It may cause decreased myocardial contractility or hypotension. However, the hemodynamic deterioration is relatively rare unless the patient suffers from severe congestive heart failure. Side effects include dizziness, sensory change, seizure, and coma. † Oral amiodarone rarely causes hemodynamic changes, while intravenous amiodarone often induces peripheral vasodilation, hypotension, or bradycardia. Recommended initial loading dose is 150 mg over 10 min followed by infusion of 0.5-1.0 mg/min. The speed of infusion of the initial loading (150 mg) may be reduced (for example, 150 mg over 1-4 hours) in patients with hypotension or congestive heart failure. A narrow QRS tachycardia in a 78 year-old male patient with biliary sepsis. Tachycardia was irregularly irregular with a heart rate of about 260 beats per minutes. Blood pressure decreased from 100 to 70mmHg due to the rapid heart rate. After infusion of intravenous diltiazem, heart rate was decreased to 160 beats per minutes, but blood pressure remained low at 70-80mmHg. Change to intravenous amiodarone (150mg over 2 hours, then continuous infusion at a rate of 0.5mg/min) further decreased heart rate to 130 beats per minutes with blood pressure increased to 90mmHg. 
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